Prostate Cancer
Conference Coverage
Experts Focus on Quality-of-Life Data in Prostate Cancer
Trials presented at ASCO explore the effects of treatment suspension or intensification on health-related QoL and interventions to manage side...
From the Journals
New Screening Protocol May Improve Prostate Cancer Detection
A new trial assesses a screening intervention that aims to reduce unnecessary diagnoses of prostate cancer but still catch relevant cancers and...
Conference Coverage
How Long Should Active Surveillance Last?
New data “suggest that meticulous follow-up is needed over a longer time” than previous studies have shown.
Latest News
Meat Linked to Higher Erectile Dysfunction Risk
NYU urologist discusses impact of a plant-based diet on heart health, prostate cancer, and sexual health.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
Feature
New Trials in Prostate Cancer: Could Your Patient Benefit?
Two new trials for patients with metastatic castration-resistant prostate cancer that involve remaining on therapy until disease progression...
Feature
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.
Latest News
New Guidelines: Start PSA Screening Earlier in Black Men
Multidisciplinary panel suggests lowering the screening age to 40-45 for PSA testing in Black men.
Feature
Higher Prostate Cancer Rates Seen in Black Men, but Advanced Cases Similar to White Men
Pros and cons of establishing different “normal” PSA levels for different races discussed.
Latest News
Outside the Guidelines: Denosumab Overuse in Prostate Cancer
For patients with metastatic castration-sensitive disease the bone-modifying agents show no benefit in preventing skeletal-related events, are not...
From the Journals
Is MRI Screening Unnecessarily High in Prostate Cancer?
Expert emphasizes the necessity of observing a decrease in overall prostate cancer incidence before asserting that the current cancer diagnostics...